RBX1 and esophageal squamous cell carcinoma: To investigate whether targeting ROC1 could act as a novel chemosensitizer to increase the anti-ESCC activity of CDDP, we treated ESCC cells TE1 and Kyse450 with DMSO or CDDP after siROC1 transfection.